The link between Alzheimer’s and Down syndrome
A blood test developed at UNT Health Science Center to detect Alzheimer’s disease will be used in a new study that focuses on individuals with Down syndrome, who are at high risk of developing memory problems.
The study is one of four exploring the link between Alzheimer’s disease and Down syndrome that are receiving $250,000 grants from the Alzheimer’s Association, the Crnic Institute for Down Syndrome and the Global Down Syndrome Foundation. The goal is to bolster development of a simple, inexpensive, noninvasive test that can detect the risk of Alzheimer’s disease.
The study is being led by Nicole Schupf, PhD, Professor of Epidemiology at Columbia University Medical Center in New York City, and Sid O’Bryant, PhD, Director of the Center for Alzheimer’s and Neurodegenerative Disease Research at UNT Health Science Center.
“Prevention of Alzheimer’s dementia may be more effective and easily achieved than attempting to treat the disease once symptoms already exist and irreversible damage to the brain has already occurred,” said Dean Hartley, PhD, Director of Science Initiatives for the Alzheimer’s Association. “For this approach to be successful, we must be able to simply and accurately assess risk early in the disease process.”
“Autopsy is still the only way to definitively diagnose Alzheimer’s disease,” said Michelle Sie Whitten, President and CEO of the Global Down Syndrome Foundation. “If these researchers are successful we will be one step closer to catching Alzheimer’s in its early stages and hopefully then be able to treat people with the disease earlier and actually prevent dementia from occurring, when new treatment options become available.”
Nearly all adults with Down syndrome begin developing the brain changes of Alzheimer’s in their 30s. By age 55 or 60, it is estimated that between 55 percent and 70 percent of these individuals will develop dementia.
Because people with Down syndrome are at high risk for Alzheimer’s, answers to important research questions about the disease may be developed more quickly in this population than by studying people with sporadic, late-onset Alzheimer’s, where symptoms appear most often after age 65 – and in many cases not until the 70s or 80s.
Scientists are not sure exactly why individuals with Down syndrome are at high risk for Alzheimer’s disease but past research shows that a gene on chromosome 21 codes for the amyloid precursor protein (APP) that gets cut into fragments that accumulate into the hallmark amyloid brain plaques of Alzheimer’s. People with Down syndrome are born with an extra copy of chromosome 21.
“Our research could provide new information about potential biomarkers, including protein changes detected in blood, that could more accurately and easily predict the risk for Alzheimer’s disease in people with Down syndrome,” Dr. Schupf said. “If successful, we believe there is a chance that these biomarkers could also be used to assess Alzheimer’s risk in all groups of people.”
The Alzheimer’s Association is the largest nonprofit funder of Alzheimer’s research, having awarded more than $350 million to over 2,300 projects since 1982. The Association currently supports more than 350 ongoing research projects in 21 countries totaling more than $82 million.
The Global Down Syndrome Foundation raises funds for the Crnic Institute for Down Syndrome to underwrite critical research benefiting people with Down syndrome. To date, $5.7 million in research grants has been given to 33 investigators.
By Sally Crocker UNTHSC students, faculty and staff are invited to the 2nd Annual Zoonotic Disease Fair from noon to 3 p.m. on Nov. 21 to learn about some of the common diseases found in Texas that can be passed from animals to humans. “It pays to be aware,” said public health st...Read more
Nov 16, 2017
By Alex Branch Amy Raines Milenkov, MPH, DrPH, has always cared about the underdog. She cared about the low-income women and children afflicted with HIV or AIDS who she helped as a social worker in the 1990s, when life-saving drug cocktails were only emerging. She cared for the vu...Read more
Nov 13, 2017
By Jan Jarvis Catherine Daniel, a first-year student in the Texas College of Osteopathic Medicine, clicked on the keys of her laptop, searching for data about a program to address infant mortality in Tarrant County. “There needs to be a better way of identifying high risk people,” she ...Read more
Nov 13, 2017
By Alex Branch Gary and Aundrea Palladino met while serving in the U.S. Air Force as pharmacy technicians at Joint Base Andrews in Washington, D.C. At the three pharmacies on base, Gary and Aundrea filled prescriptions and managed inventory, compounded IV and topical medication orders, and...Read more
Nov 9, 2017